Trending Now

Private equity investments to revive in India in second half of 2025: Report

NTR commences dubbing for actioner ‘War 2’

Crisis brews in Kerala CPI after leaked audio targets state secretary Binoy Viswam

Cambodia to take the ongoing border dispute with Thailand to ICJ

US host cities outline legacy vision for 2026 FIFA World Cup

11/06/2025
  • About
  • Write for Us
  • Advertise
  • Contact
Nation Press Logo
  • HOME
  • INDIA
  • INTERNATIONAL
  • ENTERTAINMENT
  • BUSINESS
  • SPORTS
  • SCIENCE/TECH
  • HEALTH/MEDICINE
  • Web Stories
×
  1. Home
  2. Search

Search Posts FDA approval


Celltrion Secures Interchangeability Approval for Humira Biosimilar in the U.S.

Celltrion Secures Interchangeability Approval for Humira Biosimilar in the U.S.

April 14, 2025
Research Unveils Innovative Drug Delivery System for Rare Eye Cancer

Research Unveils Innovative Drug Delivery System for Rare Eye Cancer

April 11, 2025
Celltrion Aims for $3.46 Billion in Sales This Year Powered by Biosimilars

Celltrion Aims for $3.46 Billion in Sales This Year Powered by Biosimilars

March 18, 2025
Celltrion Unveils New Treatment for Autoimmune Disorders in the US

Celltrion Unveils New Treatment for Autoimmune Disorders in the US

March 13, 2025
Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

March 10, 2025
Celltrion's Biosimilars for Bone Disorders Gain US Approval

Celltrion's Biosimilars for Bone Disorders Gain US Approval

March 4, 2025
FDA Greenlights New Painkillers to Combat Opioid Addiction Risks

FDA Greenlights New Painkillers to Combat Opioid Addiction Risks

February 1, 2025
Celltrion Secures FDA Approval for New Autoimmune Disease Biosimilar

Celltrion Secures FDA Approval for New Autoimmune Disease Biosimilar

January 31, 2025
Eli Lilly's Zepbound Positioned to Lead the Global Obesity Sector: Report

Eli Lilly's Zepbound Positioned to Lead the Global Obesity Sector: Report

December 31, 2024
Four Oral GLP-1R Drugs Compete for Approval, Led by Novo Nordisk: Report

Four Oral GLP-1R Drugs Compete for Approval, Led by Novo Nordisk: Report

December 2, 2024

Follow Us

Popular Posts

  • Did Rana Daggubati Really Express His Love for Biryani During the ‘Rana Naidu’ Shoot?

    Did Rana Daggubati Really Express His Love for Biryani During the ‘Rana Naidu’ Shoot?

    11/06/2025
  • Will Private Equity Investments in India Revive in the Second Half of 2025?

    Will Private Equity Investments in India Revive in the Second Half of 2025?

    11/06/2025
  • Has NTR Started Dubbing for the Action-Packed ‘War 2’?

    Has NTR Started Dubbing for the Action-Packed ‘War 2’?

    11/06/2025
  • How will PM Modi's tribute to Sant Kabir Das be remembered?

    How will PM Modi's tribute to Sant Kabir Das be remembered?

    11/06/2025
  • Is a Crisis Unfolding in Kerala CPI with Leaked Audio Targeting State Secretary Binoy Viswam?

    Is a Crisis Unfolding in Kerala CPI with Leaked Audio Targeting State Secretary Binoy Viswam?

    11/06/2025

Categories

  • India News
  • International News
  • Business News
  • Sports News
  • Entertainment News
  • Science/Tech News
  • Health/Medicine News

Newsletter

Subscribe to our newsletter to receive the latest news and updates

Tags

Pahalgam attack Caste census Modi News IPL 2025 Sensex News Technology News Health News Sports News Rahul Gandhi News

About Us

Nation Press is your premier source for the latest news, updates, and in-depth coverage across a wide range of topics. Our dedicated team of journalists works around the clock to bring you accurate, timely, and engaging content.

Quick Links

  • About Us
  • Contact Us
  • Advertise
  • Privacy Policy
  • Disclaimer
  • Cookie Policy
  • Terms & Conditions

Newsletter

Subscribe to our newsletter to receive the latest news and updates.

© 2025 Nation Press. All Rights Reserved.